Full video transcriptClick to expand
Auto-generated transcript of @iron.mike.en's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00I'm having cruciate ligament surgery soon, should I take BPC-157 or TB-500 before or after.
- 0:06I wouldn't recommend taking any of these peptides at all, but maybe I'll just throw out a study
- 0:11that looked into exactly this kind of thing.
- 0:14Of course it was done on mice, and a heads up to all animal lovers, something pretty
- 0:19barbaric was done, because they compare the group of mice, or respectively two groups
- 0:24of mice by dropping a heavy weight on their heads.
- 0:28Yeah, really.
- 0:29One group got BPC-157 30 minutes before, and the other group didn't.
- 0:35They found that the healing process was incredibly fast in the group with BPC-157 compared to the
- 0:42placebo group, so they found that the healing acceleration with BPC-157 was really strong
- 0:48compared to not using BPC-157.
- 0:51This means you should ideally start such regimens before an injury, but also continue them throughout
- 0:57the healing period.
BPC-157 and knee surgery recovery: what the mouse studies actually show
Quick answer
BPC-157 has shown accelerated soft tissue healing in multiple rodent trauma models, primarily in research by Sikiric et al., but no randomized controlled human trials have established efficacy, dosing, or safety for perioperative use in ligament surgery. The compound is not FDA-approved and was removed from the FDA's list of bulk substances permissible for compounding in 2023. Patients considering peptides around a surgical procedure should disclose use to their surgeon, as effects on angiogenesis and inflammatory signaling could interact with graft healing in ways that remain unstudied.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
BPC-157 access requires the right clinical path
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 6 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For BPC-157 and knee surgery recovery: what the mouse studies actually show, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Multifunctionality and Possible Medical Application of the BPC 157 Peptide
Used to frame BPC-157 as an investigational peptide with mixed preclinical and limited human evidence.
PubMed
Gastric pentadecapeptide BPC 157 and its role in accelerating musculoskeletal soft tissue healing
Supports cautious tissue-repair context without presenting BPC-157 as an approved therapy.
PubMed
beta-Thymosins
Background source for thymosin biology and tissue-repair mechanisms.
PubMed
Thymosin beta 4 and the eye: the journey from bench to bedside
Shows how thymosin beta-4 evidence differs by route, tissue, and clinical application.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
BPC-157 should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.
Claim path
Keep researching this bpc-157 video claims cluster
Best for searchers trying to separate BPC-157 research signals from overconfident recovery claims.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "BPC-157 and knee surgery recovery: what the mouse studies actually show" from IronMikeEn. We read the clip as a Peptide social video fact-checks claim about BPC-157, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: BPC-157 has shown accelerated soft tissue healing in multiple rodent trauma models, primarily in research by Sikiric et al.
The reason this review is not generic is the source wording and the canonical claim label "peptides for informational purposes only not medical advice cruciate." In this clip, the useful excerpt is: "I'm having cruciate ligament surgery soon, should I take BPC-157 or TB-500 before or after." That wording changes the review because it points to BPC-157 safety, access, evidence, and fit, not a one-size-fits-all protocol.
The source trail for this page is checked against Multifunctionality and Possible Medical Application of the BPC 157 Peptide (2025), Gastric pentadecapeptide BPC 157 and its role in accelerating musculoskeletal soft tissue healing (2019), and Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review (2025), plus the creator's own wording. BPC-157 still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
BPC-157 has shown accelerated soft tissue healing in multiple rodent trauma models, primarily in research by Sikiric et al.
FormBlends verdict
BPC-157 safety, access, evidence, and fit
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with the BPC-157 guide, safety notes, access rules, and a licensed-provider review.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- BPC-157 has shown accelerated soft tissue healing in multiple rodent trauma models, primarily in research by Sikiric et al., but no randomized controlled human trials have established efficacy, dosing, or safety for perioperative use in ligament surgery. The compound is not FDA-approved and was removed from the FDA's list of bulk substances permissible for compounding in 2023. Patients considering peptides around a surgical procedure should disclose use to their surgeon, as effects on angiogenesis and inflammatory signaling could interact with graft healing in ways that remain unstudied.
- BPC-157 animal studies (Sikiric et al., multiple publications 1993-2020) consistently show faster soft tissue healing in rodents, but zero randomized controlled human trials exist for perioperative ligament surgery use.
- The mouse model described uses blunt crush trauma, not surgical ligament transection. These are meaningfully different injury types and healing mechanisms.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- BPC-157 decisions still need source quality, legal access, and provider oversight checks.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against the BPC-157 guide, cost path, safety notes, and provider review before acting.
Review BPC-157What You'll Learn
- BPC-157 animal studies (Sikiric et al., multiple publications 1993-2020) consistently show faster soft tissue healing in rodents, but zero randomized controlled human trials exist for perioperative ligament surgery use.
- The mouse model described uses blunt crush trauma, not surgical ligament transection. These are meaningfully different injury types and healing mechanisms.
- BPC-157 was removed from the FDA's list of permissible bulk compounding substances in 2023, meaning it cannot be legally compounded for human use in the United States.
- Pre-surgical exercise rehabilitation (prehabilitation) has actual human trial support for improving ACL surgery outcomes, per Eitzen et al. (2010, American Journal of Sports Medicine).
- The creator's framing that timing matters in healing biology is scientifically plausible in principle, but the leap to a specific pre-surgery peptide protocol is not supported by human evidence.
- Anyone considering any supplement or compound before surgery must disclose it to their surgical team. BPC-157's effects on angiogenesis and inflammation have not been studied in the context of graft surgery.
- The creator's opening disclaimer (they would not recommend these peptides) is more responsible than most peptide content online, but it does not substitute for the regulatory and safety context that was largely absent from the video.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @iron.mike.en actually say?
The creator, facing cruciate ligament surgery, walked through a mouse study comparing BPC-157 to placebo in a trauma model. Credit where it's due: they opened by saying "I wouldn't recommend taking any of these peptides at all," which is a more honest disclaimer than most peptide content on this platform manages. They then described a study where one group of mice received BPC-157 30 minutes before injury and healed significantly faster than the placebo group. The takeaway they landed on: "you should ideally start such regimens before an injury, but also continue them throughout the healing period." That's a meaningful distinction from the usual "take this and heal faster" framing, but it still carries real problems worth unpacking.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
IronMikeEn · TikTok creator
8.7K views on this video
⚠️ For informational purposes only, not medical advice. 🦵🏽Cruciate ligament surgery ahead? Some look into peptides like BPC-157 or TB-500 for recovery. 💡 In a mouse study, BPC-157 given before injury accelerated healing dramatically compared to placebo. 👉🏾 So timing may matter: before and during healing. 💬 What’s your take, would you ever consider peptides for recovery? Comment below 👇🏾 📌 Save & share if you’re curious about recovery science. #injuryrecovery #kneesurgery #fitnes #heali
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about bpc-157 animal studies (sikiric et al., multiple publications 1993-2020) consistently?
BPC-157 animal studies (Sikiric et al., multiple publications 1993-2020) consistently show faster soft tissue healing in rodents, but zero randomized controlled human trials exist for perioperative ligament surgery use.
What does the video say about the mouse model described uses blunt crush trauma, not surgical?
The mouse model described uses blunt crush trauma, not surgical ligament transection. These are meaningfully different injury types and healing mechanisms.
What does the video say about bpc-157 was removed from the fda's list of permissible bulk?
BPC-157 was removed from the FDA's list of permissible bulk compounding substances in 2023, meaning it cannot be legally compounded for human use in the United States.
What does the video say about pre-surgical exercise rehabilitation (prehabilitation) has actual human trial support for?
Pre-surgical exercise rehabilitation (prehabilitation) has actual human trial support for improving ACL surgery outcomes, per Eitzen et al. (2010, American Journal of Sports Medicine).
What does the video say about the creator's framing?
The creator's framing that timing matters in healing biology is scientifically plausible in principle, but the leap to a specific pre-surgery peptide protocol is not supported by human evidence.
What does the video say about anyone considering any supplement?
Anyone considering any supplement or compound before surgery must disclose it to their surgical team. BPC-157's effects on angiogenesis and inflammation have not been studied in the context of graft surgery.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by IronMikeEn, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.